Abstracts
Call For Abstracts Now Open!
Abstract Submission
Abstract submissions are invited for consideration for Infection Prevention 2024, which will be held in Birmingham, UK on 23 – 25 September 2024.
Submitting an abstract at a conference is an excellent way to communicate the outcomes of your research project with fellow practitioners, researchers and educationalists. Presenting will also support your personal development, showcase your skills and help grow your CV.
Each year there are over 100 posters presented and 12 oral paper presentations at conference. We do hope you consider submitting an abstract.
Abstracts are welcome in any one of the following categories:
An abstract can be submitted for presentation at the Conference as one of the following categories:
At the review stage, the Programme Committee may change the presentation preference submitted by the author to ensure the continuity of the conference programme i.e. oral presentation may be changed to poster presentation OR poster presentation to oral presentation. The presenting Author will be informed of any change to their submitted presentation preference at the acceptance notification stage. The decision of the programme committee is final.
Oral presentations will be 13 minutes long with 2 minutes for questions and answers
Accepted posters will be asked to produce a poster for display at the conference. Presenters are asked to take note of the following guidelines when producing their poster:
• Maximum poster size is A0 (0.84 x 1.19m) (portrait orientation) • Keep text to a minimum • Ensure any text is in large font • Use graphs, charts, and/or tables • Ensure contents have a logical flow • Make it colourful • Removal and collection of posters at the end of the display period remains the responsibility of the presenter. Posters not removed by the indicated take down time will be removed and disposed of.
A poster talk will include 5-6 authors, who will all have approximately 5 mins to talk about their poster at a designated poster talk session.
All abstracts that are accepted as posters will be considered for a poster talk.
Please indicate during submission if you would NOT like your poster to be included in the chance of being part of a poster talk. This is not guaranteed, but a selection of posters will be chosen to be part of a poster talk.
Abstracts that have been previously presented at another Conference will not be considered for presentation and authors will be asked to confirm this when submitting the abstract. Please email conference@ips.uk.net if you are unsure about submitting previously presented work.
Each year the Scientific Program Committee ‘may’ give an award for the ‘Best Oral Presentation’ and/or the ‘Best Poster Presentation’ or any other such category the committee deem appropriate. These will be judged by a panel appointed by the Scientific Program Committee using a scoring based system to ensure a fair process. If awarded, these will be presented to the lead author only and may be accompanied by an associated prize which will be determined by the Scientific Program Committee. Awards may be presented at conference and/or published in IPS communications post conference, this will be communicated in advance.
Submission Process
The abstract submission process for IP2024 is through an online submission portal
IMPORTANT INFORMATION ON THE SUBMISSION PROCESS
The Presenting Author must submit the abstract and will act as the main point of contact for the abstract with organisers.
Once you enter the online submission portal, start by creating an account. Please keep a record of the account details you use to set up the account as you will require them to log into the IP2024 abstract submission portal. Upon successful submission of the abstract a confirmation email will be sent to the Presenting Author.
If you have not received a confirmation email, please check that your abstract is not left in draft and is fully submitted by logging back into the portal and checking on the Edit/View Abstracts page.
You can save your submission as a draft and return to edit the submission at a later point. It is important to note that once it has been submitted the abstract cannot be edited after the abstract submission deadline. Ensure that your abstract is not left in draft as it will not be reviewed.
The online abstract submission is a simple step-by-step process and will ask you to input the following details:
It is ESSENTIAL that you read the guidelines below before you submit. Abstracts which do not adhere to the guidelines will not be reviewed. Abstract Template Abstracts must be formatted using the IP2024 template. The Abstract word limit is 300, (word limit includes: references; excludes: title, authors and affiliations) and must include the following sections as set out in the abstract template:
Download the template below to create the abstract and then save as a Word file to upload to the system. Only WORD files will be accepted for upload. Graphs and tables may not be included in the abstract. Abstracts will not be edited and will be added to the conference website and/or conference app as submitted. Ensure that all grammar and spelling is correct.
All abstracts will go through a blind peer-review carried out by reviewers selected by the IP2024 Programme Committee.
Notification of acceptance or rejection will be sent to the submitter on 25 July 2024.
When notified of acceptance, the Presenting Author is required to accept the offer by registering for the conference and paying in full by 5 August 2024. You will be provided with a link to register at this rate in your acceptance email.
If a presenter fails to register by 5 August they:
If you need to withdraw the abstract or change the presenting author contact conference@ips.uk.net by 5 August.
If you have any queries regarding the above, please contact the IP2024 Programme Team conference@ips.uk.net
2023 Winner Best Poster Award
Amy Boden - Associate Director of Nursing Operations/ Deputy DIPC and IPS West Midlands Branch Coordinator
Title: The Introduction of an Infection Prevention Nursing Associate in a targeted Clostridoides difficile intervention